Litfulo (generic name: rituximab) is a monoclonal antibody used
primarily for the treatment of certain types of blood cancers
and autoimmune diseases. It is commonly used in conditions such
as:
1. *Non-Hodgkin Lymphoma (NHL)*: Litfulo is used to treat
specific types of NHL in adults.
2. *Chronic Lymphocytic Leukemia (CLL)*: It can be part of the
treatment regimen for CLL.
3. *Rheumatoid Arthritis*: Rituximab is used in combination
with other medications to treat moderate to severe rheumatoid
arthritis in adults who have had an inadequate response to
other treatments.
4. *Granulomatosis with Polyangiitis (Wegener's
Granulomatosis)* and *Microscopic Polyangiitis*: Rituximab is
used to treat these severe autoimmune diseases.
The use of Litfulo must be determined by a healthcare provider,
taking into account the specific health condition, treatment
goals, and potential side effects. If you are considering this
medication, or if you have specific questions about its use,
you should consult your healthcare provider for personalized
medical advice.
